Haemonetics Corporation (HAE)
Pretax margin
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 212,071 | 164,748 | 158,860 | 146,988 | 151,865 | 161,077 | 159,272 | 167,499 | 141,403 | 124,104 | 113,268 | 92,131 | 63,629 | 20,905 | 26,891 | 61,925 | 72,913 | 122,270 | 122,725 | 112,857 |
| Revenue (ttm) | US$ in thousands | 1,360,824 | 1,373,515 | 1,361,223 | 1,333,895 | 1,309,055 | 1,270,181 | 1,239,232 | 1,218,534 | 1,168,660 | 1,129,246 | 1,083,714 | 1,026,126 | 993,196 | 953,223 | 933,825 | 903,414 | 870,463 | 883,926 | 902,525 | 945,605 |
| Pretax margin | 15.58% | 11.99% | 11.67% | 11.02% | 11.60% | 12.68% | 12.85% | 13.75% | 12.10% | 10.99% | 10.45% | 8.98% | 6.41% | 2.19% | 2.88% | 6.85% | 8.38% | 13.83% | 13.60% | 11.93% |
March 31, 2025 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $212,071K ÷ $1,360,824K
= 15.58%
The pretax margin of Haemonetics Corporation has fluctuated over the periods analyzed. Starting at 11.93% in June 2020, there was a steady increase until December 2020, reaching 13.83%. However, there was a decline in the following quarters, dropping to 2.19% by December 2021. Subsequent quarters saw some recovery, with the pretax margin gradually improving to 15.58% by March 2025. Despite fluctuations, the company was able to maintain positive pretax margins throughout the period, indicating its ability to generate profits before accounting for taxes relative to its revenue. The highest pretax margin was observed in March 2025, reflecting an improvement in the company's operational efficiency and profitability.
Peer comparison
Mar 31, 2025